Viewing Study NCT00429559


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2025-12-27 @ 4:29 AM
Study NCT ID: NCT00429559
Status: COMPLETED
Last Update Posted: 2011-07-22
First Post: 2007-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma
Sponsor: Hellenic Oncology Research Group
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CT/06.14
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: A.Kalykaki
Old Organization: Hellenic Oncology Research Group

Collaborators

Collaborators

Name Class View
None OTHER View